65 employees
Altor BioScience researches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases.
2002
$15M
from 1 investors over 1 rounds
Altor Bioscience Corporation raised $15M on August 27, 2008
Investors: Sanderling Ventures